Lucas-Ruiz Fernando, Fernández-Nogales Marta, Valiente-Soriano Francisco J, Herrera Macarena, Nadal-Nicolás Francisco M, Agudo-Barriuso Marta, Herrera Eloisa
Grupo de Investigación Oftalmología Experimental, Departamento de Oftalmología, Otorrinolaringología y Anatomía Patológica, Facultad de Medicina, Universidad de Murcia, Instituto Murciano de Investigación Biosanitaria (IMIB), Campus de Ciencias de la Salud, Optometría, Murcia, 30120, Spain.
Instituto de Neurociencias de Alicante (Consejo Superior de Investigaciones Científicas, Universidad Miguel Hernández, CSIC-UMH), Av. Santiago Ramón y Cajal s/n. Sant Joan d'Alacant 03550, Alicante, Spain.
Sci Rep. 2025 May 3;15(1):15503. doi: 10.1038/s41598-025-00283-0.
The ciliary body (CB) has been proposed as a niche of neural stem cells because, in vitro, cells from this area are able to form neurospheres, proliferate and differentiate. Here, we explore the potential of CB cells to differentiate and replace degenerated retinal ganglion cells (RGCs) in vivo. CB cells and cells from the subventricular zone (SVZ) were isolated from adult or postnatal C57BL/6Tg(CAG-EGFP) mice, respectively, and intravitreally injected into intact retinas, immediately after optic nerve crush or 45 days after the lesion of adult C57/BL/6 mice. Retinas were analysed in whole mounts or cross sections at different time points. Controls were matched untreated retinas. Neither cell type caused gliosis or toxicity when injected into intact retinas. When CB or SVZ cells were injected right after axotomy, they formed an epimembrane without integrating in the retina. However, when CB cells were administered in retinas depleted of RGCs, they integrated into the ganglion cell layer and expressed RGC and neuronal markers. Although SVZ cells were also able to integrate into RGC depleted retinas they did so more slowly than CB cells. These results shed light in the long-standing question of whether cells in the CB have the potential to transdifferentiate in vivo and point to the CB as a suitable source of cells that could be used in cell-replacement therapies for neurodegenerative diseases of the retina.
睫状体(CB)已被提议作为神经干细胞的一个微环境,因为在体外,该区域的细胞能够形成神经球、增殖并分化。在此,我们探究了CB细胞在体内分化并替代退化的视网膜神经节细胞(RGCs)的潜力。分别从成年或出生后的C57BL/6Tg(CAG-EGFP)小鼠中分离出CB细胞和脑室下区(SVZ)的细胞,并在视神经挤压后立即或成年C57/BL/6小鼠损伤45天后将其玻璃体内注射到完整的视网膜中。在不同时间点对视网膜进行整体装片或横切分析。对照组为未处理的匹配视网膜。当注射到完整视网膜中时,这两种细胞类型均未引起胶质增生或毒性。当在轴突切断后立即注射CB或SVZ细胞时,它们形成了一个膜上结构但未整合到视网膜中。然而,当将CB细胞注射到RGCs缺失的视网膜中时,它们整合到神经节细胞层并表达RGC和神经元标记物。尽管SVZ细胞也能够整合到RGCs缺失的视网膜中,但它们的整合速度比CB细胞慢。这些结果为CB中的细胞在体内是否具有转分化潜力这一长期存在的问题提供了线索,并指出CB是可用于视网膜神经退行性疾病细胞替代疗法的合适细胞来源。